Catalyst
Slingshot members are tracking this event:
NDA of Patisiran for Familial Amyloidotic Polyneuropathy in patients with ATTR to be filed late 2017, assuming positive data
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 16, 2017
Occurred Source:
http://investors.alnylam.com/releasedetail.cfm?ReleaseID=1048984
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Patisiran, Apollo Trial, Familial Amyloidotic Polyneuropathy, Attr, Nda, Bpc
